Creative Medical Technology (CELZ) late Thursday filed a preliminary prospectus for securities offering.
The filing covers a best efforts public offering of about 3.0 million shares and warrants to purchase up to some 6.1 million shares at a combined assumed price of $1.97 per share and accompanying warrants. Investors can also buy pre-funded warrants in lieu.
The use of proceeds includes for clinical studies, working capital and general corporate purposes, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments